Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-Fluoride PET Bone Scans Versus Traditional 99mTc-MDP Gamma Camera Bone Scans for the Diagnosis of Bone Metastases: a Blinded, Prospective Trial

NCT01254929 is registered in ClinicalTrials.gov with Seattle Nuclear Medicine as lead sponsor.

NCT NCT01254929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01254929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-Fluoride PET Bone Scans Versus Traditional 99mTc-MDP Gamma Camera Bone Scans for the Diagnosis of Bone Metastases: a Blinded, Prospective Trial
Lead sponsor
Seattle Nuclear Medicine
Phase
Observational
Overall status
Completed
Start date
December 31, 2010
Completion date
March 31, 2020
Enrollment
299 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, cancer